These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 14558702)

  • 21. A critical review on the use of modern sophisticated hyphenated tools in the characterization of impurities and degradation products.
    Singh S; Handa T; Narayanam M; Sahu A; Junwal M; Shah RP
    J Pharm Biomed Anal; 2012 Oct; 69():148-73. PubMed ID: 22521633
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Application of mid-IR spectroscopy for the characterization of pharmaceutical systems.
    Van Eerdenbrugh B; Taylor LS
    Int J Pharm; 2011 Sep; 417(1-2):3-16. PubMed ID: 21167267
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microwave-assisted heterogeneous cross-coupling reactions catalyzed by nickel-in-charcoal (Ni/C).
    Lipshutz BH; Frieman BA; Lee CT; Lower A; Nihan DM; Taft BR
    Chem Asian J; 2006 Sep; 1(3):417-29. PubMed ID: 17441078
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Strategy for determining extractables from rubber packaging materials in drug products.
    Paskiet DM
    PDA J Pharm Sci Technol; 1997; 51(6):248-51. PubMed ID: 9448435
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitation and characterization of process impurities and extractables in protein-containing solutions using proton NMR as a general tool.
    Skidmore K; Hewitt D; Kao YH
    Biotechnol Prog; 2012; 28(6):1526-33. PubMed ID: 22915490
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Types of filtration.
    Levy RV; Jornitz MW
    Adv Biochem Eng Biotechnol; 2006; 98():1-26. PubMed ID: 16570860
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmaceutical impurities and degradation products: uses and applications of NMR techniques.
    Maggio RM; Calvo NL; Vignaduzzo SE; Kaufman TS
    J Pharm Biomed Anal; 2014 Dec; 101():102-22. PubMed ID: 24853620
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identifying and Mitigating Errors in Screening for Organic Extractables and Leachables: Part 1-Introduction to Errors in Chromatographic Screening for Organic Extractables and Leachables and Discussion of the Errors of Omission.
    Christiaens P; Beusen JM; Verlinde P; Baeten J; Jenke D
    PDA J Pharm Sci Technol; 2020; 74(1):90-107. PubMed ID: 31209164
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alternative solvent-free methodologies in the synthesis of pharmaceutical drugs.
    Shearouse WC; Waddell DC; Mack J
    Curr Opin Drug Discov Devel; 2009 Nov; 12(6):772-83. PubMed ID: 19894189
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transfer of NIR calibrations for pharmaceutical formulations between different instruments.
    Bergman EL; Brage H; Josefson M; Svensson O; Sparén A
    J Pharm Biomed Anal; 2006 Apr; 41(1):89-98. PubMed ID: 16406454
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preuse/Poststerilization Integrity Testing (PUPSIT): To Do or Not to Do?
    Gupta VS; Jindal J; Gupta A; Gupta NK
    PDA J Pharm Sci Technol; 2020; 74(3):301-308. PubMed ID: 31732690
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification, characterization and quantification of a new impurity in deferasirox active pharmaceutical ingredient by LC-ESI-QT/MS/MS.
    Thomas S; Chandra Joshi S; Vir D; Agarwal A; Rao RD; Sridhar I; Xavier CM; Mathela CS
    J Pharm Biomed Anal; 2012 Apr; 63():112-9. PubMed ID: 22361658
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Validation of manufacturing process of Diltiazem HCl tablets by NIR spectrophotometry (NIRS).
    Bodson C; Rozet E; Ziemons E; Evrard B; Hubert P; Delattre L
    J Pharm Biomed Anal; 2007 Oct; 45(2):356-61. PubMed ID: 17628385
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Applications of process analytical technology to crystallization processes.
    Yu LX; Lionberger RA; Raw AS; D'Costa R; Wu H; Hussain AS
    Adv Drug Deliv Rev; 2004 Feb; 56(3):349-69. PubMed ID: 14962586
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Real-time endpoint monitoring and determination for a pharmaceutical salt formation process with in-line FT-IR spectroscopy.
    Lin Z; Zhou L; Mahajan A; Song S; Wang T; Ge Z; Ellison D
    J Pharm Biomed Anal; 2006 Apr; 41(1):99-104. PubMed ID: 16321495
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Extractables analysis of single-use flexible plastic biocontainers.
    Marghitoiu L; Liu J; Lee H; Perez L; Fujimori K; Ronk M; Hammond MR; Nunn H; Lower A; Rogers G; Nashed-Samuel Y
    PDA J Pharm Sci Technol; 2015; 69(1):49-58. PubMed ID: 25691714
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polymorph characterization of active pharmaceutical ingredients (APIs) using low-frequency Raman spectroscopy.
    Larkin PJ; Dabros M; Sarsfield B; Chan E; Carriere JT; Smith BC
    Appl Spectrosc; 2014; 68(7):758-76. PubMed ID: 25014842
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of current compendial physiochemical test procedures for pharmaceutical elastomeric closures and development of an improved HPLC procedure.
    Milano CJ; Bailey LC
    PDA J Pharm Sci Technol; 1999; 53(4):202-10. PubMed ID: 10754713
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sterilizing filtration of liposome and related lipid-containing solutions: enhancing successful filter qualification.
    Folmsbee M; Moussourakis M
    PDA J Pharm Sci Technol; 2012; 66(2):161-7. PubMed ID: 22492601
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification, isolation and characterization of process related impurities in ezetimibe.
    Guntupalli S; Ray UK; Murali N; Gupta PB; Kumar VJ; Satheesh D; Islam A
    J Pharm Biomed Anal; 2014 Jan; 88():385-90. PubMed ID: 24176742
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.